TY - JOUR
T1 - Progress with rotavirus vaccines
T2 - Summary of the Tenth International Rotavirus Symposium
AU - Parashar, Umesh
AU - Steele, Duncan
AU - Neuzil, Kathleen
AU - Quadros, Ciro De
AU - Tharmaphornpilas, Piyanit
AU - Serhan, Fatima
AU - Santosham, Mathu
AU - Patel, Manish
AU - Glass, Roger
N1 - Funding Information:
M Santosham has served on the Scientific Advisory Board of both Merck and GlaxoSmithKline. He is also the chair of the Data & Safety Monitoring Board for 116E (Bharat Biotech) vaccine trial. K Neuzil is employed at PATH, which receives grants related to rotavirus vaccine development and research from the GAVI Alliance and the Bill and Melinda Gates Foundation. C de Quadros is employed at the Sabin Institute, which has received grants from both GlaxoSmithKline and Merck that were used to support the Rotavirus Symposium held in Bangkok. R Glass is a government employee and through CDC has been involved with patents for an inactivated rotavirus vaccine and the Indian neonatal vaccine strain, 116E, being developed by the Government of India and the Gates Foundation, CDC and NIH, and Stanford. The CDC has received royalties from companies interested in testing the inactivated rotavirus vaccines and R Glass has received some funds from these agreements. F Serhan works at the WHO, which receives funds from the GAVI Alliance to support the rotavirus global surveillance network. U Parashar and M Patel are CDC employees and do not have any relevant financial disclosures. D Steele and P Tharmaphornpilas do not have any financial disclosures. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
PY - 2013/2
Y1 - 2013/2
N2 - Tenth International Rotavirus Symposium Bangkok, Thailand, 19-21 September 2012 Over 350 scientific, public and private sector experts from 47 countries convened at the Tenth International Rotavirus Symposium in Bangkok, Thailand on 19-21 September 2012 to discuss progress in the prevention and control of rotavirus, the leading cause of diarrhea hospitalizations and deaths among young children worldwide. Participants discussed data on the burden and epidemiology of rotavirus disease, results of trials of rotavirus vaccines, postmarketing data on vaccine impact and safety from countries that have implemented rotavirus vaccination programs, new insights in rotavirus pathogenesis, immunity and strain diversity, and key issues related to vaccine policy and introduction.
AB - Tenth International Rotavirus Symposium Bangkok, Thailand, 19-21 September 2012 Over 350 scientific, public and private sector experts from 47 countries convened at the Tenth International Rotavirus Symposium in Bangkok, Thailand on 19-21 September 2012 to discuss progress in the prevention and control of rotavirus, the leading cause of diarrhea hospitalizations and deaths among young children worldwide. Participants discussed data on the burden and epidemiology of rotavirus disease, results of trials of rotavirus vaccines, postmarketing data on vaccine impact and safety from countries that have implemented rotavirus vaccination programs, new insights in rotavirus pathogenesis, immunity and strain diversity, and key issues related to vaccine policy and introduction.
UR - http://www.scopus.com/inward/record.url?scp=84874048440&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84874048440&partnerID=8YFLogxK
U2 - 10.1586/erv.12.148
DO - 10.1586/erv.12.148
M3 - Article
C2 - 23414403
AN - SCOPUS:84874048440
SN - 1476-0584
VL - 12
SP - 113
EP - 117
JO - Expert review of vaccines
JF - Expert review of vaccines
IS - 2
ER -